Fred Alger Management LLC Sells Shares of CareDx, Inc in 2023.
Trending News ☀️ CAREDX ($NASDAQ:CDNA): Fred Alger Management LLC sold shares of CareDx, Inc in 2023. CareDx, Inc is a [...]
CareDx Reports Q4 Beat, Issues FY 2023 Revenue Guidance Below Consensus Estimate
Trending News 🌥️ CAREDX ($NASDAQ:CDNA): CareDx recently released its fourth quarter financial results and reported non-GAAP earnings per share (EPS) [...]
Quantbot Technologies LP Profits from Selling 26677 Shares of CareDx, in 2023.
Trending News ☀️ CAREDX ($NASDAQ:CDNA): Quantbot Technologies LP recently sold 26677 of its shares in CareDx, Inc., a biotechnology company [...]
Duality Advisers LP Boosts Stake in CareDx,
Trending News ☀️ CAREDX ($NASDAQ:CDNA): Duality Advisers LP has recently increased its stake in CareDx, Inc., a molecular diagnostics company [...]
CareDx Projects Record Revenues and 4% Year-on-Year Growth for 2022 Fourth Quarter
Trending News ☀️ Caredx Intrinsic Stock Value – CAREDX ($NASDAQ:CDNA) is a leading precision medicine solutions company in the healthcare [...]
Reginald Seeto Dumps 2818 Shares of CareDx, Inc Stock
Trending News 🌧️ CAREDX ($NASDAQ:CDNA) is a leading precision medicine company focused on the discovery, development and commercialization of clinically [...]
CareDx Inc Closes 1.04% Lower Despite Market Strength
Trending News 🌧️ Caredx Intrinsic Stock Value – CAREDX ($NASDAQ:CDNA): CareDx Inc is a molecular diagnostics company that provides products [...]
CAREDX plans to buyback $50 million of their shares over the next 24 months
Trending News ☀️ Caredx Intrinsic Value – CAREDX ($NASDAQ:CDNA) is a publicly-traded company that plans to buyback $50 million of [...]
Value Hunters: Look To CareDx Inc For Promising Returns
Trending News ☀️ Caredx Inc Intrinsic Value – Caredx Inc ($NASDAQ:CDNA) is a publicly traded company on the Nasdaq stock [...]
Early Intervention Can Reduce the Need for Expensive Treatments
Trending News 🌥️ CAREDX ($NASDAQ:CDNA) is a molecular diagnostics company that uses genomics to improve organ transplant outcomes. The company’s [...]
